Free Trial

Stratec (ETR:SBS) Shares Up 2% - Still a Buy?

Stratec logo with Medical background

Stratec SE (ETR:SBS - Get Free Report) shares shot up 2% on Monday . The stock traded as high as €25.45 ($28.28) and last traded at €25.45 ($28.28). 10,207 shares were traded during mid-day trading, an increase of 63% from the average session volume of 6,253 shares. The stock had previously closed at €24.95 ($27.72).

Stratec Stock Down 0.6 %

The company's fifty day simple moving average is €30.09 and its 200-day simple moving average is €32.92. The company has a debt-to-equity ratio of 66.97, a current ratio of 2.52 and a quick ratio of 1.65. The firm has a market capitalization of $284.12 million, a PE ratio of 28.38, a price-to-earnings-growth ratio of 10.43 and a beta of 0.16.

About Stratec

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

Read More

Should You Invest $1,000 in Stratec Right Now?

Before you consider Stratec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stratec wasn't on the list.

While Stratec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines